Abstract
HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) is an antioxidant gene that plays a key role in activating antioxidant pathways to maintain cellular homeostasis. Recent studies suggest that the antioxidant gene HACE1 may be a potential therapeutic target for age-related degenerative diseases. However, its role in intervertebral disc degeneration (IDD) has not been reported in any study. To clarify the role of HACE1 in IDD, we performed in vivo and in vitro basal experiments. The MRI results indicated that the degeneration grade of intervertebral discs in old rats was significantly higher compared to that in juvenile rats. Additionally, the expression of HACE1 in the degenerated intervertebral discs of aged rats was reduced. In cellular experiments, HACE1 overexpression could restore IL-1β-induced apoptosis, mitochondrial damage and iron overload. In animal experiments, HACE1 activated antioxidant signaling pathways, attenuated oxidative stress, and increased the expression of ECM and anti-ferroptosis proteins. In summary, HACE1 alleviates the progression of IDD by inhibiting oxidative stress and ferroptosis in nucleus pulposus cells. Its protective effect may be related to the activation of the Nrf2/ARE signaling pathway. In conclusion, our results support that the antioxidant gene HACE1 could serve as a novel potential target for treating IDD.
Data availability
All other data in this study are included in the published manuscript and supplementary information files.
References
Gao, B. et al. Discovery and application of postnatal nucleus pulposus progenitors essential for intervertebral disc homeostasis and degeneration. Adv. Sci. 9, 2104888. https://doi.org/10.1002/advs.202104888 (2022).
Collaborators, G. B. D. L. B. P. Global, regional, and National burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. 5, e316–e329. https://doi.org/10.1016/S2665-9913(23)00098-X (2023).
Chen, F. et al. Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop. Bone Res. 8, 10. https://doi.org/10.1038/s41413-020-0087-2 (2020).
Wang, Z. J. et al. Ion elemental-optimized layered double hydroxide nanoparticles promote chondrogenic differentiation and intervertebral disc regeneration of mesenchymal stem cells through focal adhesion signaling pathway. Bioactive Mater. 22, 75–90. https://doi.org/10.1016/j.bioactmat.2022.08.023 (2023).
Wu, X. H. et al. Targeting the IL-1β/IL-1Ra pathways for the aggregation of human islet amyloid polypeptide in an ex vivo organ culture system of the intervertebral disc. Exp. Mol. Med. 51, 110. https://doi.org/10.1038/s12276-019-0310-7 (2019).
Wang, Y. D. et al. Oxidative stress in intervertebral disc degeneration: molecular mechanisms, pathogenesis and treatment. Cell. Proliferat. 56 https://doi.org/10.1111/cpr.13448 (2023).
Wu, L. L. et al. miR-124-3p delivered by exosomes from Heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia-reperfusion injury in steatotic grafts. J. Nanobiotechnol. 20, 196. https://doi.org/10.1186/s12951-022-01407-8 (2022).
Fan, C. Y. et al. The role of ferroptosis in intervertebral disc degeneration. Front. Cell. Dev. Biol. 11, 1219840. https://doi.org/10.3389/fcell.2023.1219840 (2023).
Chen, Q. et al. Mitochondrial-targeted metal-phenolic nanoparticles to attenuate intervertebral disc degeneration: alleviating oxidative stress and mitochondrial dysfunction. ACS Nano. 18, 8885–8905. https://doi.org/10.1021/acsnano.3c12163 (2024).
Li, J. et al. Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses. Cell. Mol. Biol. Lett. 27, 29. https://doi.org/10.1186/s11658-022-00318-8 (2022).
Rao, J. H. et al. Macrophage nuclear factor erythroid 2-related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3-mediated RhoA/ROCK pathway in the ischemic liver. Hepatology 75, 1429–1445. https://doi.org/10.1002/hep.32184 (2022).
Rotblat, B. et al. HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response. Proc. Natl. Acad. Sci. USA. 111, 3032–3037. https://doi.org/10.1073/pnas.1314421111 (2014).
Da, C. X. et al. HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells. Signal. Transduct. Tar. 6, 399. https://doi.org/10.1038/s41392-021-00793-z (2021).
Wang, J. et al. Small molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration. Exp. Mol. Med. 50, 1–14. https://doi.org/10.1038/s12276-018-0173-3 (2018).
Jiang, C. et al. Inhibition of EZH2 ameliorates cartilage endplate degeneration and attenuates the progression of intervertebral disc degeneration via demethylation of Sox-9. Ebiomedicine 48, 619–629. https://doi.org/10.1016/j.ebiom.2019.10.006 (2019).
Guo, Z. et al. Injectable nanocomposite hydrogels for intervertebral disc degeneration: combating oxidative stress, mitochondrial dysfunction, and ferroptosis. Adv. Healthc. Mater. 14, e2403892. https://doi.org/10.1002/adhm.202403892 (2025).
Ma, X. et al. Effect of lentivirus-mediated survivin transfection on the morphology and apoptosis of nucleus pulposus cells derived from degenerative human disc in vitro. Int. J. Mol. Med. 36, 186–194. https://doi.org/10.3892/ijmm.2015.2225 (2015).
Yang, R. Z. et al. Involvement of oxidative stress-induced annulus fibrosus cell and nucleus pulposus cell ferroptosis in intervertebral disc degeneration pathogenesis. J. Cell. Physiol. 236, 2725–2739. https://doi.org/10.1002/jcp.30039 (2021).
Lee, S. G., Brownmiller, C. R., Lee, S. O. & Kang, H. W. Anti-Inflammatory and antioxidant effects of anthocyanins of trifolium pratense (Red Clover) in Lipopolysaccharide-Stimulated RAW-267.4 macrophages. Nutrients. 12 https://doi.org/10.3390/nu12041089 (2020).
Lei, G. et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell. Res. 30, 146–162. https://doi.org/10.1038/s41422-019-0263-3 (2020).
Kang, L. et al. The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance. Cell. Prolif. 53, e12779. https://doi.org/10.1111/cpr.12779 (2020).
Kang, L. et al. Restoration of autophagic flux rescues oxidative damage and mitochondrial dysfunction to protect against intervertebral disc degeneration. Oxid. Med. Cell. Longev. 2019, 7810320. https://doi.org/10.1155/2019/7810320 (2019).
Zhou, R. P. et al. TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKCa-NOX4 axis. Redox Biol. 55, 102411. https://doi.org/10.1016/j.redox.2022.102411 (2022).
Yang, X. et al. Bleomycin induces fibrotic transformation of bone marrow stromal cells to treat height loss of intervertebral disc through the TGFβR1/Smad2/3 pathway. Stem Cell. Res. Ther. 12, 34. https://doi.org/10.1186/s13287-020-02093-9 (2021).
Huang, B. et al. Activation of Nrf2 signaling by 4-octyl Itaconate attenuates the cartilaginous endplate degeneration by inhibiting E3 ubiquitin ligase ZNF598. Osteoarthr. Cartil. 31, 213–227. https://doi.org/10.1016/j.joca.2022.10.008 (2023).
Shao, Z. et al. Senolytic agent Quercetin ameliorates intervertebral disc degeneration the Nrf2/NF-κB axis. Osteoarthr. Cartil. 29, 413–422. https://doi.org/10.1016/j.joca.2020.11.006 (2021).
Zhu, J. et al. The deubiquitinase USP11 ameliorates intervertebral disc degeneration by regulating oxidative stress-induced ferroptosis via deubiquitinating and stabilizing Sirt3. Redox Biol. 62, 102707. https://doi.org/10.1016/j.redox.2023.102707 (2023).
Yin, P. Y. et al. HACE1 expression in heart failure patients might promote mitochondrial oxidative stress and ferroptosis by targeting NRF2. Aging-Us 15, 13888–13900. https://doi.org/10.18632/aging.205272 (2023).
Li, H. T. et al. IL-1β-mediated inflammatory responses in intervertebral disc degeneration: Mechanisms, signaling pathways, and therapeutic potential. Heliyon. 9, e19951. https://doi.org/10.1016/j.heliyon.2023.e19951 (2023).
Zhou, H. et al. Microenvironment-responsive metal-phenolic network release platform with ROS scavenging, anti-pyroptosis, and ECM regeneration for intervertebral disc degeneration. Bioactive Mater. 37, 51–71. https://doi.org/10.1016/j.bioactmat.2024.02.036 (2024).
Xia, J. et al. HACE1 as a Bridge between oxidative stress and autophagy. Front. Immunol. 16, 1595601. https://doi.org/10.3389/fimmu.2025.1595601 (2025).
Baird, L., Lleres, D., Swift, S. & Dinkova-Kostova, A. T. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc. Natl. Acad. Sci. U. S. A. 110, 15259–15264. https://doi.org/10.1073/pnas.1305687110 (2013).
Horie, Y. et al. Molecular basis for the disruption of Keap1-Nrf2 interaction via hinge & latch mechanism. Commun. Biol. 4, 576. https://doi.org/10.1038/s42003-021-02100-6 (2021).
Xu, X. et al. Co-Treatment with Resveratrol and FGF1 protects against acute liver toxicity after doxorubicin treatment via the AMPK/NRF2 pathway. Front. Pharmacol. 13, 940406. https://doi.org/10.3389/fphar.2022.940406 (2022).
George, M., Tharakan, M., Culberson, J., Reddy, A. P. & Reddy, P. H. Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases. Ageing Res. Rev. 82, 101756. https://doi.org/10.1016/j.arr.2022.101756 (2022).
Dinkova-Kostova, A. T., Kostov, R. V. & Kazantsev, A. G. The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J. 285, 3576–3590. https://doi.org/10.1111/febs.14379 (2018).
Zhang, Y. K. et al. Nordihydroguaiaretic acid suppresses ferroptosis and mitigates intervertebral disc degeneration through the NRF2/GPX4 axis. Int. Immunopharmacol. 143, 113590. https://doi.org/10.1016/j.intimp.2024.113590 (2024).
Liu, P. F. et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell. Mol. Biol. Lett. 25 https://doi.org/10.1186/s11658-020-00205-0 (2020).
Acknowledgements
We thank the Graduate Education Innovation Project of Guizhou Province and the Graduate Research Fund of Zunyi Medical University for providing fund support.
Funding
This work was supported by the Graduate Education Innovation Project of Guizhou Province [No. 2024YJSKYJJ342] and the Graduate Research Fund of Zunyi Medical University [No. ZYK242].
Author information
Authors and Affiliations
Contributions
The author contributions were as follows: Z.X. and J.X. designed the experiments, Y.J., S.F., J.Y. and Z.W. conducted the in vitro experiments, and W.Z., Q.X., Y.Z., H.D. and J.X. conducted in vivo experiments. J.X., L.Z. and T.L. analyzed the data and wrote the manuscript, and Z.X. revised the manuscript.
Corresponding author
Ethics declarations
Ethical approval and consent to participate
This study was approved by the Experimental Animal Welfare and Ethics Committee of the Affiliated Hospital of Zunyi Medical University (No. zyfy-an-2023-0217). And the study followed the ARRIVE guidelines (https://arriveguidelines.org).
Consent for publication
All authors gave their consent for publication.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Xia, J., Zhang, W., Jiang, Y. et al. HACE1 alleviates intervertebral disc degeneration by inhibiting ferroptosis in nucleus pulposus cells. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39017-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-39017-1
